Multimodal MRI neuroimaging biomarkers for cognitive normal adults, amnestic mild cognitive impairment, and Alzheimer's disease

Neurology Research International

Volumn 2012, Issue , 2012, Pages

  Lin, Ai Ling ^a   Laird, Angela R ^a   Fox, Peter T ^a   Gao, Jia Hong ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866153565     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2012/907409     Document Type: Review

References (93)

1. Hebert L. E., Scherr P. A., Bienias J. L., Bennett D. A., Evans D. A., Alzheimer disease in the US population: prevalence estimates using the 2000 census. Archives of Neurology 2003 60 8 1119 1122 2-s2.0-0042023711 10.1001/archneur.60.8.1119 (Pubitemid 36975801)
2. Mueller S. G., Weiner M. W., Thal L. J., Petersen R. C., Jack C. R., Jagust W., Trojanowski J. Q., Toga A. W., Beckett L., Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's disease neuroimaging initiative (ADNI). Alzheimer's and Dementia 2005 1 1 55 66 2-s2.0-33144484244 10.1016/j.jalz.2005.06.003 (Pubitemid 43348857)
3. Mohs R. C., Marin D., Haroutunian V., Fillit H., O'Connell A. W., Early clinical and biological manifestations of Alzheimer's disease: implications for screening and treatment. Drug Discovery and Development for Alzheimer's Disease 2002 New York, NY, USA Springer
4. Frisoni G. B., Structural imaging in the clinical diagnosis of Alzheimer's disease: problems and tools. Journal of Neurology Neurosurgery and Psychiatry 2001 70 6 711 718 2-s2.0-0034979264 10.1136/jnnp.70.6.711 (Pubitemid 32554195)
5. Kochunov P., Mangin J. F., Coyle T., Lancaster J., Thompson P., Rivière D., Cointepas Y., Régis J., Schlosser A., Royall D. R., Zilles K., Mazziotta J., Toga A., Fox P. T., Age-related morphology trends of cortical sulci. Human Brain Mapping 2005 26 3 210 220 2-s2.0-27744479697 10.1002/hbm.20198 (Pubitemid 41598319)
6. Desikan R. S., Cabral H. J., Settecase F., Hess C. P., Dillon W. P., Glastonbury C. M., Weiner M. W., Schmansky N. J., Salat D. H., Fischl B., Automated MRI measures predict progression to Alzheimer's disease. Neurobiology of Aging 2010 31 8 1364 1374 2-s2.0-77954031857 10.1016/j.neurobiolaging.2010. 04.023
7. Desikan R. S., Cabral H. J., Hess C. P., Dillon W. P., Glastonbury C. M., Weiner M. W., Schmansky N. J., Greve D. N., Salat D. H., Buckner R. L., Fischl B., Automated MRI measures identify individuals with mild cognitive impairment and Alzheimers disease. Brain 2009 132 8 2048 2057 2-s2.0-67749133648 10.1093/brain/awp123
8. Yang W., Lui R. L.M., Gao J. -H., Chan T. F., Yau S. -T., Sperling R. A., Huang X., xhuang3@partners.org Independent component analysis-based classification of Alzheimer's disease MRI data. Journal of Alzheimer's Disease 2011 24 4 775 783 10.3233/JAD-2011-101371
9. Kochunov P., Thompson P. M., Lancaster J. L., Bartzokis G., Smith S., Coyle T., Royall D. R., Laird A., Fox P. T., Relationship between white matter fractional anisotropy and other indices of cerebral health in normal aging: tract-based spatial statistics study of aging. NeuroImage 2007 35 2 478 487 2-s2.0-33947215462 10.1016/j.neuroimage.2006.12.021 (Pubitemid 46420428)
10. Kochunov P., Williamson D. E., Lancaster J., Fox P., Cornell J., Blangero J., Glahn D. C., Fractional anisotropy of water diffusion in cerebral white matter across the lifespan. Neurobiology of Aging. In press 10.1016/j. neurobiolaging.2010.01.014
11. Biswal B., Yetkin F. Z., Haughton V. M., Hyde J. S., Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magnetic Resonance in Medicine 1995 34 4 537 541 2-s2.0-0029166541 10.1002/mrm.1910340409
12. Cordes D., Haughton V. M., Arfanakis K., Wendt G. J., Turski P. A., Moritz C. H., Quigley M. A., Meyerand M. E., Mapping functionally related regions of brain with functional connectivity MR imaging. American Journal of Neuroradiology 2000 21 9 1636 1644 2-s2.0-0033776022
13. Rapoport S. I., Coupled reductions in brain oxidative phosphorylation and synaptic function can be quantified and staged in the course of Alzheimer disease. Neurotoxicity Research 2003 5 6 385 397 2-s2.0-1342269756 10.1007/BF03033167
14. Xiong J., Parsons L. M., Gao J. H., Fox P. T., Interregional connectivity to primary motor cortex revealed using MRI resting state images. Human Brain Mapping 1999 8 2-3 151 156 2-s2.0-0032835346 10.1002/(SICI)1097-0193(1999)8:2/ 3151::AID-HBM13>3.0.CO;2-5 (Pubitemid 29480303)
15. Beckmann C. F., DeLuca M., Devlin J. T., Smith S. M., Investigations into resting-state connectivity using independent component analysis. Philosophical Transactions of the Royal Society B 2005 360 1457 1001 1013 2-s2.0-25444456446 10.1098/rstb.2005.1634 (Pubitemid 41672861)
16. Damoiseaux J. S., Rombouts S. A. R. B., Barkhof F., Scheltens P., Stam C. J., Smith S. M., Beckmann C. F., Consistent resting-state networks across healthy subjects. Proceedings of the National Academy of Sciences of the United States of America 2006 103 37 13848 13853 2-s2.0-33748796093 10.1073/pnas.0601417103 (Pubitemid 44413996)
17. Kiviniemi V., Kantola J. H., Jauhiainen J., Hyvärinen A., Tervonen O., Independent component analysis of nondeterministic fMRI signal sources. NeuroImage 2003 19 2 253 260 2-s2.0-0043240261 10.1016/S1053-8119(03)00097-1 (Pubitemid 39665677)
18. Detre J. A., Leigh J. S., Williams D. S., Koretsky A. P., Perfusion imaging. Magnetic Resonance in Medicine 1992 23 1 37 45 2-s2.0-0026508892
19. Liu H. L., Pu Y., Liu Y., Nickerson L., Andrews T., Fox P. T., Gao J. H., Cerebral blood flow measurement by dynamic contrast MRI using singular value decomposition with an adaptive threshold. Magnetic Resonance in Medicine 1999 42 1 167 172 2-s2.0-0032793622 10.1002/(SICI)1522-2594(199907)42:1167::AID- MRM22>3.0.CO;2-Q (Pubitemid 29325626)
20. Jagust W. J., Functional imaging patterns in Alzheimer's disease: relationships to neurobiology. Annals of the New York Academy of Sciences 1996 777 30 36 2-s2.0-0029923219
21. Waldemar G., Functional brain imaging with SPECT in normal aging and dementia: methodological, pathophysiological, and diagnostic aspects. Cerebrovascular and Brain Metabolism Reviews 1995 7 2 89 130 2-s2.0-0029310525
22. Simmons M. L., Frondoza C. G., Coyle J. T., Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991 45 1 37 45 2-s2.0-0026000851 10.1016/0306-4522(91)90101-S
23. Kantarci K., Petersen R. C., Boeve B. F., Knopman D. S., Tang-Wai D. F., O'Brien P. C., Weigand S. D., Edland S. D., Smith G. E., Ivnik R. J., Ferman T. J., Tangalos E. G., Jack C. R., 1H MR spectroscopy in common dementias. Neurology 2004 63 8 1393 1398 2-s2.0-7044220330
24. Gómez-Tortosa E., egomezt@fjd.es Barquero M. S., Barón M., Sainz M. J., Manzano S., Payno M., Ros R., Almaraz C., Gómez-Garré P., Jiménez-Escrig A., Variability of age at onset in siblings with familial Alzheimer disease. Archives of Neurology 2007 64 12 1743 1748 10.1001/archneur.64.12.1743 (Pubitemid 350254936)
25. Mosconi L., Mistur R., Switalski R., Brys M., Glodzik L., Rich K., Pirraglia E., Tsui W., De Santi S., De Leon M. J., Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology 2009 72 6 513 520 2-s2.0-62149115284 10.1212/01.wnl.0000333247.51383. 43
26. Mosconi L., Rinne J. O., Tsui W. H., Berti V., Li Y., Wang H., Murray J., Scheinin N., Någren K., Williams S., Glodzik L., De Santi S., Vallabhajosula S., De Leon M. J., Increased fibrillar amyloid- β burden in normal individuals with a family history of late-onset Alzheimer's. Proceedings of the National Academy of Sciences of the United States of America 2010 107 13 5949 5954 2-s2.0-77950546575 10.1073/pnas.0914141107
27. Honea R. A., Swerdlow R. H., Vidoni E. D., Goodwin J., Burns J. M., Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology 2010 74 2 113 120 2-s2.0-75649117447 10.1212/WNL.0b013e3181c918cb
28. Honea R. A., rhonea@kumc.edu Swerdlow R. H., Vidoni E. D., Burns J. M., Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease. Neurology 2011 76 9 822 829 10.1212/WNL.0b013e31820e7b74
29. Debette S., Wolf P. A., Beiser A., Au R., Himali J. J., Pikula A., Auerbach S., Decarli C., Seshadri S., Association of parental dementia with cognitive and brain MRI measures in middle-aged adults. Neurology 2009 73 24 2071 2078 2-s2.0-73349093404 10.1212/WNL.0b013e3181c67833
30. Crivello F., Lemaître H., Dufouil C., Grassiot B., Delcroix N., Tzourio-Mazoyer N., Tzourio C., Mazoyer B., Effects of ApoE- ε 4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons. NeuroImage 2010 53 3 1064 1069 2-s2.0-77956231447 10.1016/j.neuroimage.2009.12.116
31. Filippini N., Zarei M., Beckmann C. F., Galluzzi S., Borsci G., Testa C., Bonetti M., Beltramello A., Ghidoni R., Benussi L., Binetti G., Frisoni G. B., Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE ε 4 carriers. Journal of Magnetic Resonance Imaging 2009 29 5 1021 1026 2-s2.0-66149124867 10.1002/jmri.21757
32. Bookheimer S. Y., Strojwas M. H., Cohen M. S., Saunders A. M., Pericak-Vance M. A., Mazziotta J. C., Small G. W., Patterns of brain activation in people at risk for Alzheimer's disease. New England Journal of Medicine 2000 343 7 450 456 2-s2.0-0034680078 10.1056/NEJM200008173430701 (Pubitemid 30646483)
33. Filippini N., Ebmeier K. P., MacIntosh B. J., Trachtenberg A. J., Frisoni G. B., Wilcock G. K., Beckmann C. F., Smith S. M., Matthews P. M., Mackay C. E., Differential effects of the APOE genotype on brain function across the lifespan. NeuroImage 2011 54 1 602 610 2-s2.0-77957966717 10.1016/j.neuroimage. 2010.08.009
34. Douaud G., douaud@fmrib.ox.ac.uk Jbabdi S., Behrens T. E. J., Menke R. A., Gass A., Monsch A. U., Rao A., Whitcher B., Kindlmann G., Matthews P. M., Smith S., DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. NeuroImage 2011 55 3 880 890 10.1016/j.neuroimage.2010.12.008
35. Driscoll I., Davatzikos C., An Y., Wu X., Shen D., Kraut M., Resnick S. M., Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology 2009 72 22 1906 1913 2-s2.0-67650088150 10.1212/WNL.0b013e3181a82634
36. Gili T., Cercignani M., Serra L., Perri R., Giove F., Maraviglia B., Caltagirone C., Bozzali M., Regional brain atrophy and functional disconnection across Alzheimer's disease evolution. Journal of Neurology, Neurosurgery and Psychiatry 2011 82 1 58 66 2-s2.0-78650487445 10.1136/jnnp.2009.199935
37. Thompson P. M., Hayashi K. M., Dutton R. A., Chiang M. C., Leow A. D., Sowell E. R., De Zubicaray G., Becker J. T., Lopez O. L., Aizenstein H. J., Toga A. W., Tracking Alzheimer's disease. Annals of the New York Academy of Sciences 2007 1097 183 214 2-s2.0-34247623771 10.1196/annals.1379.017 (Pubitemid 47084892)
38. Thompson P. M., Hayashi K. M., De Zubicaray G. I., Janke A. L., Rose S. E., Semple J., Hong M. S., Herman D. H., Gravano D., Doddrell D. M., Toga A. W., Mapping hippocampal and ventricular change in Alzheimer disease. NeuroImage 2004 22 4 1754 1766 2-s2.0-3242679076 10.1016/j.neuroimage.2004.03.040 (Pubitemid 38962663)
39. Thompson P. M., Hayashi K. M., De Zubicaray G., Janke A. L., Rose S. E., Semple J., Herman D., Hong M. S., Dittmer S. S., Doddrell D. M., Toga A. W., Dynamics of gray matter loss in Alzheimer's disease. Journal of Neuroscience 2003 23 3 994 1005 2-s2.0-0037319171 (Pubitemid 36206191)
40. Bosch B., Arenaza-Urquijo E. M., Rami L., Sala-Llonch R., Junqué C., Solé-Padullés C., Pea-Gómez C., Bargalló N., Molinuevo J. L., Bartrés-Faz D., Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance. Neurobiology of Aging. In press 10.1016/j.neurobiolaging.2010.02.004
41. Zhang H. Y., Wang S. J., Liu B., Ma Z. L., Yang M., Zhang Z. J., Teng G. J., Resting brain connectivity: changes during the progress of Alzheimer disease. Radiology 2010 256 2 598 606 2-s2.0-77955153014 10.1148/radiol.10091701
42. Morris R. G., Kopelman M. D., The memory deficits in Alzheimer-type dementia: a review. Quarterly Journal of Experimental Psychology Section A 1986 38 4 575 602 2-s2.0-0022816660
43. Caselli R. J., Dueck A. C., Osborne D., Sabbagh M. N., Connor D. J., Ahern G. L., Baxter L. C., Rapcsak S. Z., Shi J., Woodruff B. K., Locke D. E. C., Snyder C. H., Alexander G. E., Rademakers R., Reiman E. M., Longitudinal modeling of age-related memory decline and the APOE ε 4 effect. New England Journal of Medicine 2009 361 3 255 263 2-s2.0-67650899270 10.1056/NEJMoa0809437
44. Deary I. J., Whiteman M. C., Pattie A., Starr J. M., Hayward C., Wright A. F., Carothers A., Whalley L. J., Ageing: cognitive change and the APOE ε 4 allele. Nature 2002 418 6901 932 2-s2.0-0037194718 10.1038/418932a (Pubitemid 34976020)
45. Dennis N. A., Browndyke J. N., Stokes J., Need A., Burke J. R., Welsh-Bohmer K. A., Cabeza R., Temporal lobe functional activity and connectivity in young adult APOE ε 4 carriers. Alzheimer's and Dementia 2010 6 4 303 311 2-s2.0-77956647741 10.1016/j.jalz.2009.07.003
46. Filippini N., MacIntosh B. J., Hough M. G., Goodwin G. M., Frisoni G. B., Smith S. M., Matthews P. M., Beckmann C. F., Mackay C. E., Distinct patterns of brain activity in young carriers of the APOE- ε 4 allele. Proceedings of the National Academy of Sciences of the United States of America 2009 106 17 7209 7214 2-s2.0-66349129276 10.1073/pnas.0811879106
47. Sheline Y. I., Morris J. C., Snyder A. Z., Price J. L., Yan Z., D'Angelo G., Liu C., Dixit S., Benzinger T., Fagan A., Goate A., Mintun M. A., APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF A β 42. Journal of Neuroscience 2010 30 50 17035 17040 2-s2.0-78650371044 10.1523/JNEUROSCI.3987-10.2010
48. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L. O., Nordberg A., Bäckman L., Albert M., Almkvist O., Arai H., Basun H., Blennow K., De Leon M., Decarli C., Erkinjuntti T., Giacobini E., Graff C., Hardy J., Jack C., Jorm A., Ritchie K., Van Duijn C., Visser P., Petersen R. C., Mild cognitive impairmentbeyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. Journal of Internal Medicine 2004 256 3 240 246 2-s2.0-4544350756 10.1111/j.1365-2796.2004. 01380.x (Pubitemid 39222993)
49. He J., Farias S., Martinez O., Reed B., Mungas D., DeCarli C., Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes. Archives of Neurology 2009 66 11 1393 1399 2-s2.0-70449650320 10.1001/archneurol.2009.252
50. Becker J. T., Davis S. W., Hayashi K. M., Meltzer C. C., Toga A. W., Lopez O. L., Thompson P. M., Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. Archives of Neurology 2006 63 1 97 101 2-s2.0-30344440085 10.1001/archneur.63.1.97 (Pubitemid 43063867)
51. Apostolova L. G., Steiner C. A., Akopyan G. G., Dutton R. A., Hayashi K. M., Toga A. W., Cummings J. L., Thompson P. M., Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. Archives of Neurology 2007 64 10 1489 1495 2-s2.0-34250735918 10.1001/archneur.64.10.1489 (Pubitemid 47572672)
52. Kochunov P., Ramage A. E., Lancaster J. L., Robin D. A., Narayana S., Coyle T., Royall D. R., Fox P., Loss of cerebral white matter structural integrity tracks the gray matter metabolic decline in normal aging. NeuroImage 2009 45 1 17 28 2-s2.0-60349102573 10.1016/j.neuroimage.2008.11.010
53. Vemuri P., Wiste H. J., Weigand S. D., Knopman D. S., Trojanowski J. Q., Shaw L. M., Bernstein M. A., Aisen P. S., Weiner M., Petersen R. C., Jack C. R., Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology 2010 75 2 143 151 2-s2.0-77954706306 10.1212/WNL.0b013e3181e7ca82
54. Jack C. R., Slomkowski M., Gracon S., Hoover T. M., Felmlee J. P., Stewart K., Xu Y., Shiung M., O'Brien P. C., Cha R., Knopman D., Petersen R. C., MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 2003 60 2 253 260 2-s2.0-0037469189 (Pubitemid 36152018)
55. Schroeter M. L., Stein T., Maslowski N., Neumann J., Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients. NeuroImage 2009 47 4 1196 1206 2-s2.0-67651171190 10.1016/j.neuroimage.2009.05.037
56. Chao L. L., Buckley S. T., Kornak J., Schuff N., Madison C., Yaffe K., Miller B. L., Kramer J. H., Weiner M. W., ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Disease and Associated Disorders 2010 24 1 19 27 2-s2.0-77949431792 10.1097/WAD.0b013e3181b4f736
57. Braak H., Braak E., Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 1991 82 4 239 259 2-s2.0-0025863618
58. Du A. T., Schuff N., Amend D., Laakso M. P., Hsu Y. Y., Jagust W. J., Yaffe K., Kramer J. H., Reed B., Norman D., Chui H. C., Weiner M. W., Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry 2001 71 4 441 447 2-s2.0-0034801730 10.1136/jnnp.71.4.441 (Pubitemid 32906865)
59. Callen D. J. A., Black S. E., Gao F., Caldwell C. B., Szalai J. P., Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology 2001 57 9 1669 1674 2-s2.0-0035856447 (Pubitemid 33055487)
60. Jack C. R. Jr., Petersen R. C., Xu Y. C., Waring S. C., O'Brien P. C., Tangalos E. G., Smith G. E., Ivnik R. J., Kokmen E., Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997 49 3 786 794 2-s2.0-0343416812 (Pubitemid 27428023)
61. Xu Y., Jack C. R., O'Brien P. C., Kokmen E., Smith G. E., Ivnik R. J., Boeve B. F., Tangalos R. G., Petersen R. C., Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology 2000 54 9 1760 1767 2-s2.0-0034624914 (Pubitemid 30428402)
62. De Santi S., De Leon M. J., Rusinek H., Convit A., Tarshish C. Y., Roche A., Tsui W. H., Kandil E., Boppana M., Daisley K., Wang G. J., Schlyer D., Fowler J., Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiology of Aging 2001 22 4 529 539 2-s2.0-0034974107 10.1016/S0197-4580(01)00230-5 (Pubitemid 32607736)
63. Fox N. C., Cousens S., Scahill R., Harvey R. J., Rossor M. N., Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Archives of Neurology 2000 57 3 339 344 2-s2.0-0034099077 (Pubitemid 30140520)
64. Jack C. R. Jr., Petersen R. C., Xu Y., O'Brien P. C., Smith G. E., Ivnik R. J., Tangalos E. G., Kokmen E., Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 1998 51 4 993 999 2-s2.0-0345055330 (Pubitemid 28473390)
65. Kaye J. A., Swihart T., Howieson D., Dame A., Moore M. M., Karnos T., Camicioli R., Ball M., Oken B., Sexton G., Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 1997 48 5 1297 1304 2-s2.0-0030938170 (Pubitemid 27240552)
66. Laakso M. P., Lehtovirta M., Partanen K., Riekkinen P. J., Soininen H., Hippocampus in Alzheimer's disease: a 3-year follow-up MRI study. Biological Psychiatry 1999 47 6 557 561 2-s2.0-0342980418 10.1016/S0006-3223(99)00167-5
67. Resnick S. M., Pham D. L., Kraut M. A., Zonderman A. B., Davatzikos C., Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. Journal of Neuroscience 2003 23 8 3295 3301 2-s2.0-0037996766 (Pubitemid 36531970)
68. Fox N. C., Schott J. M., Imaging cerebral atrophy: normal ageing to Alzheimer's disease. The Lancet 2004 363 9406 392 394 2-s2.0-0842283229 10.1016/S0140-6736(04)15441-X (Pubitemid 38169550)
69. Gunter J. L., Shiung M. M., Manduca A., Jack C. R., Methodological considerations for measuring rates of brain atrophy. Journal of Magnetic Resonance Imaging 2003 18 1 16 24 2-s2.0-0038449893 10.1002/jmri.10325 (Pubitemid 36791264)
70. Du A. T., Schuff N., Kramer J. H., Ganzer S., Zhu X. P., Jagust W. J., Miller B. L., Reed B. R., Mungas D., Yaffe K., Chui H. C., Weiner M. W., Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology 2004 62 3 422 427 2-s2.0-10744224408 (Pubitemid 38200854)
71. Jack C. R. Jr., Shiung M. M., Gunter J. L., O'Brien P. C., Weigand S. D., Knopman D. S., Boeve B. F., Ivnik R. J., Smith G. E., Cha R. H., Tangalos E. G., Petersen R. C., Comparison of different MRI brain athrophy rate measures with clinical disease progression in AD. Neurology 2004 62 4 591 600 2-s2.0-10744231722 (Pubitemid 38252801)
72. De Leon M. J., Desanti S., Zinkowski R., Mehta P. D., Pratico D., Segal S., Clark C., Kerkman D., Debernardis J., Li J., Lair L., Reisberg B., Tsui W., Rusinek H., MRI and CSF studies in the early diagnosis of Alzheimer's disease. Journal of Internal Medicine 2004 256 3 205 223 2-s2.0-4544306699 10.1111/j.1365-2796.2004.01381.x (Pubitemid 39222990)
73. Convit A., De Leon M. J., Tarshish C., De Santi S., Tsui W., Rusinek H., George A., Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiology of Aging 1997 18 2 131 138 2-s2.0-0030741609 10.1016/S0197-4580(97)00001-8 (Pubitemid 27355930)
74. Golomb J., Kluger A., de Leon M. J., Ferris S. H., Convit A., Mittelman M. S., Cohen J., Rusinek H., De Santi S., George A. E., Hippocampal formation size in normal human aging: a correlate of delayed secondary memory performance. Learning Memory 1994 1 1 45 54 2-s2.0-0028427915 (Pubitemid 2113960)
75. Lerch J. P., Pruessner J. C., Zijdenbos A., Hampel H., Teipel S. J., Evans A. C., Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. Cerebral Cortex 2005 15 7 995 1001 2-s2.0-17644376338 10.1093/cercor/bhh200 (Pubitemid 40848068)
76. Tosun D., Mojabi P., Weiner M. W., Schuff N., Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging. NeuroImage 2010 52 1 186 197 2-s2.0-77953322948 10.1016/j.neuroimage.2010.04.033
77. Salat D. H., Greve D. N., Pacheco J. L., Quinn B. T., Helmer K. G., Buckner R. L., Fischl B., Regional white matter volume differences in nondemented aging and Alzheimer's disease. NeuroImage 2009 44 4 1247 1258 2-s2.0-58149279269 10.1016/j.neuroimage.2008.10.030
78. Damoiseaux J. S., Smith S. M., Witter M. P., Sanz-Arigita E. J., Barkhof F., Scheltens P., Stam C. J., Zarei M., Rombouts S. A. R. B., White matter tract integrity in aging and alzheimer's disease. Human Brain Mapping 2009 30 4 1051 1059 2-s2.0-63849118737 10.1002/hbm.20563
79. Qiu A., Oishi K., Miller M. I., Lyketsos C. G., Mori S., Albert M., Surface-based analysis on shape and fractional anisotropy of white matter tracts in Alzheimer's disease. PloS one 2010 5 3, article e9811
80. Spreng R. N., Mar R. A., Kim A. S. N., The common neural basis of autobiographical memory, prospection, navigation, theory of mind, and the default mode: a quantitative meta-analysis. Journal of Cognitive Neuroscience 2009 21 3 489 510 2-s2.0-63149177167 10.1162/jocn.2008.21029
81. Buckner R. L., Andrews-Hanna J. R., Schacter D. L., The brain's default network: anatomy, function, and relevance to disease. Annals of the New York Academy of Sciences 2008 1124 1 38 2-s2.0-41949121294 10.1196/annals.1440.011 (Pubitemid 351506788)
82. Greicius M. D., Srivastava G., Reiss A. L., Menon V., Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proceedings of the National Academy of Sciences of the United States of America 2004 101 13 4637 4642 2-s2.0-1842427969 10.1073/pnas.0308627101 (Pubitemid 38437463)
83. Royall D., Gao J. H., Zhao X., Polk M. J., Kellogg D., Asymmetric insular function predicts positional blood pressure in nondemented elderly. Journal of Neuropsychiatry and Clinical Neurosciences 2009 21 2 173 180 2-s2.0-67749097712 10.1176/appi.neuropsych.21.2.173
84. Royall D. R., Gao J. H., Kellogg D. L., Insular Alzheimer's disease pathology as a cause of age-related autonomic dysfunction and mortality in the non-demented elderly. Medical Hypotheses 2006 67 4 747 758 2-s2.0-33745949718 10.1016/j.mehy.2005.10.036 (Pubitemid 44062146)
85. Chao L. L., Schuff N., Kramer J. H., Du A. T., Capizzano A. A., O'Neill J., Wolkowitz O. M., Jagust W. J., Chui H. C., Miller B. L., Yaffe K., Weiner M. W., Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients. Neurology 2005 64 2 282 289 2-s2.0-19944431158
86. Pfefferbaum A., Adalsteinsson E., Spielman D., Sullivan E. V., Lim K. O., In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. Archives of General Psychiatry 1999 56 2 185 192 2-s2.0-0033001444 10.1001/archpsyc.56.2.185 (Pubitemid 29081394)
87. Nagata K., Kondoh Y., Atchison R., Sato M., Satoh Y., Watahiki Y., Hirata Y., Yokoyama E., Vascular and metabolic reserve in Alzheimer's disease. Neurobiology of Aging 2000 21 2 301 307 2-s2.0-0034603607 10.1016/S0197-4580(00) 00130-5 (Pubitemid 30387089)
88. Reiman E. M., Caselli R. J., Chen K., Alexander G. E., Bandy D., Frost J., Declining brain activity in cognitively normal apolipoprotein E ε 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2001 98 6 3334 3339 2-s2.0-0035853154 10.1073/pnas.061509598 (Pubitemid 32220846)
89. An H., Lin W., Quantitative measurements of cerebral blood oxygen saturation using magnetic resonance imaging. Journal of Cerebral Blood Flow and Metabolism 2000 20 8 1225 1236 2-s2.0-0033882689 (Pubitemid 30636758)
90. Lu H., Ge Y., Quantitative evaluation of oxygenation in venous vessels using T2-relaxation-under-spin-tagging MRI. Magnetic Resonance in Medicine 2008 60 2 357 363 2-s2.0-49049091751 10.1002/mrm.21627
91. Yablonskiy D. A., Quantitation of intrinsic magnetic susceptibility- related effects in a tissue matrix. Phantom study. Magnetic Resonance in Medicine 1998 39 3 417 428 2-s2.0-0031907230 10.1002/mrm.1910390312 (Pubitemid 28128385)
92. He X., Yablonskiy D. A., Quantitative BOLD: mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: default state. Magnetic Resonance in Medicine 2007 57 1 115 126 2-s2.0-33846085587 10.1002/mrm.21108 (Pubitemid 46067942)
93. He X., Zhu M., Yablonskiy D. A., Validation of oxygen extraction fraction measurement by qBOLD technique. Magnetic Resonance in Medicine 2008 60 4 882 888 2-s2.0-53549089633 10.1002/mrm.21719